Lessee, Operating Lease, Liability, to be Paid of IDEXX LABORATORIES INC /DE from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
IDEXX LABORATORIES INC /DE quarterly Lessee, Operating Lease, Liability, to be Paid in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • IDEXX LABORATORIES INC /DE Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2025 was $153,489,000, a 4.6% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Change (%)

IDEXX LABORATORIES INC /DE Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $153,489,000 +$6,705,000 +4.6% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $155,084,000 +$10,183,000 +7% 30 Jun 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 $139,351,000 -$6,000,000 -4.1% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $140,034,000 -$522,000 -0.37% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $146,784,000 +$3,668,000 +2.6% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $144,901,000 +$6,301,000 +4.5% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $145,351,000 +$6,682,000 +4.8% 31 Mar 2024 10-Q 01 May 2024 2024 Q1
Q4 2023 $140,556,000 -$2,101,000 -1.5% 31 Dec 2023 10-K 22 Feb 2024 2023 FY
Q3 2023 $143,116,000 +$12,957,000 +10% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $138,600,000 +$2,259,000 +1.7% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $138,669,000 +$14,803,000 +12% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $142,657,000 +$20,451,000 +17% 31 Dec 2022 10-K 16 Feb 2023 2022 FY
Q3 2022 $130,159,000 +$4,637,000 +3.7% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $136,341,000 +$12,493,000 +10% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $123,866,000 +$12,816,000 +12% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $122,206,000 +$12,602,000 +11% 31 Dec 2021 10-K 16 Feb 2022 2021 FY
Q3 2021 $125,522,000 +$23,545,000 +23% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $123,848,000 +$22,502,000 +22% 30 Jun 2021 10-Q 30 Jul 2021 2021 Q2
Q1 2021 $111,050,000 +$14,692,000 +15% 31 Mar 2021 10-Q 04 May 2021 2021 Q1
Q4 2020 $109,604,000 +$10,579,000 +11% 31 Dec 2020 10-K 12 Feb 2021 2020 FY
Q3 2020 $101,977,000 +$3,630,000 +3.7% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $101,346,000 -$1,073,000 -1% 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $96,358,000 -$4,787,000 -4.7% 31 Mar 2020 10-Q 30 Apr 2020 2020 Q1
Q4 2019 $99,025,000 31 Dec 2019 10-K 14 Feb 2020 2019 FY
Q3 2019 $98,347,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $102,419,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $101,145,000 31 Mar 2019 10-Q 01 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.